These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4571149)

  • 1. [Atelectasis--instability of the pulmonary alveolus based on surface chemistry].
    Yoshida S
    Kokyu To Junkan; 1973 Mar; 21(3):192-200. PubMed ID: 4571149
    [No Abstract]   [Full Text] [Related]  

  • 2. The pulmonary surfactant.
    Pariente R
    Pathobiol Annu; 1972; 2():381-403. PubMed ID: 4272608
    [No Abstract]   [Full Text] [Related]  

  • 3. [The presence of the "surfactant-system" in the lung as a condition for the repression of upper respiratory tract diseases. 3. Clinical material].
    Wildeboer-Venema FN
    Ned Tijdschr Geneeskd; 1971 Sep; 115(37):1533-8. PubMed ID: 5109628
    [No Abstract]   [Full Text] [Related]  

  • 4. The alveolar lining layer: a review of studies on its role in pulmonary mechanics and in the pathogenesis of atelectasis, by Mary Ellen Avery, MD, Pediatrics, 1962:30:324-330.
    Jobe CA
    Pediatrics; 1998 Jul; 102(1 Pt 2):234-6. PubMed ID: 9651439
    [No Abstract]   [Full Text] [Related]  

  • 5. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs].
    Puchkov GF; Iazvinskiĭ II
    Sov Med; 1975 Aug; (8):62. PubMed ID: 1105810
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiopathology of idiopathic respiratory distress syndrome (author's transl)].
    Valls Soler A; Sanjurjo P
    An Esp Pediatr; 1976; 9(4):423-37. PubMed ID: 990051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary surfactants and their role in lung disease.
    Scarpelli EM
    Adv Pediatr; 1969; 16():177-210. PubMed ID: 4899057
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pulmonary surfactant].
    Murakami K; Ono K; Fujiwara T; Sawada H; Mori I
    Nihon Ishikai Zasshi; 1971 Jul; 66(1):100-16. PubMed ID: 4254974
    [No Abstract]   [Full Text] [Related]  

  • 9. Respiratory distress syndrome in the tiny baby.
    Kling P
    Neonatal Netw; 1986 Apr; 4(5):7-13. PubMed ID: 3634184
    [No Abstract]   [Full Text] [Related]  

  • 10. Surfactant--a review for pediatric surgeons.
    McCabe AJ; Wilcox DT; Holm BA; Glick PL
    J Pediatr Surg; 2000 Dec; 35(12):1687-700. PubMed ID: 11101717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the surface conditions of the pulmonari alveoli as the cause of atelectases and disorders of the respiratory mechanism].
    Schoedel W; Rüfer B
    Dtsch Med Wochenschr; 1968 Aug; 93(35):1623-8. PubMed ID: 5666885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between atelectasis and surfactants].
    Ogawa J
    Nihon Ishikai Zasshi; 1971 Jul; 66(1):85-93. PubMed ID: 5109618
    [No Abstract]   [Full Text] [Related]  

  • 13. Paraquat poisoning as an experimental model of the idiopathic respiratory distress syndrome.
    Robertson B
    Bull Physiopathol Respir (Nancy); 1973; 9(6):1433-52. PubMed ID: 4802080
    [No Abstract]   [Full Text] [Related]  

  • 14. Physiology and pathology of pulmonary surfactants.
    Scarpelli EM
    Triangle; 1971; 10(2):47-56. PubMed ID: 5170861
    [No Abstract]   [Full Text] [Related]  

  • 15. Lung surfactant--a natural detergent.
    Horwitz C
    S Afr Med J; 1972 Dec; 46(49):1931-2. PubMed ID: 4678923
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiological aspects of the respiratory distress syndrome (report) (author's transl)].
    Schoedel W
    Verh Dtsch Ges Pathol; 1971; 55():2-12. PubMed ID: 4130726
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of pulmonary arteriolar constriction and arteriovenous shunting in pulmonary hypoperfusion syndrome (respiratory distress syndrome of the newborn). Summary.
    Krahl VE
    Bibl Anat; 1969; 10():220. PubMed ID: 5409302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Membrane syndrome (respiratory distress syndrome) in newborn infants. Pathogenesis and therapy with special regard to alveolar surface active agent].
    Keuth U
    Fortschr Med; 1973 Jun; 91(16):693-7. PubMed ID: 4740218
    [No Abstract]   [Full Text] [Related]  

  • 19. [For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments].
    Storme L; Truffert P; Rakza T; Lequien P
    Arch Pediatr; 1999 May; 6(5):549-55. PubMed ID: 10370813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant and RDS in premature infants.
    Lynch RG
    FASEB J; 2004 Oct; 18(13):1624. PubMed ID: 15466362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.